Macrophage polarization as a novel weapon in conditioning tumor microenvironment for bladder cancer: can we turn demons into gods?
C. Rubio, E. Munera Maravilla, I. Lodewijk, Cristian Suárez Cabrera, V. Karaivanova, R. Ruiz Palomares, Jesús María Paramio González, M. Dueñas
págs. 391-403
págs. 404-411
págs. 412-419
Antonio Gómez Caamaño, Carmen González San Segundo, I. Henríquez, Javier Maldonado Pijoan, Almudena Zapatero Laborda
págs. 420-432
Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer
págs. 433-442
págs. 443-450
Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study
Neus Esteve Pérez, Ana Ferrer Robles, G. Gómez Romero, D. Fabián Gonzalez, M. Verd-Rodríguez, Luis Carlos Mora Fernández, Juan José Segura Sampedro, Silvia Tejada Gavela, Rafael Morales Soriano
págs. 451-458
Isabel Blancas López-Barajas, E. Aguirre Ortega, S. Morales Murillo, María Luisa Gonzálvez, Sònia Servitja Tormo, Maria Nieves Díaz Fernandez, Sonia del Barco Berrón, Agustí Barnadas i Molins, Mireia Margelí Vila, I. García Carbonero, Antonio Llombart Cussac
págs. 459-466
Ruth Vera García, María José Otero López, Francisco Ayala de la Peña, Cristina González Pérez, María Ángeles Peñuelas Huertas, Juan Manuel Sepúlveda Sánchez, Núria Quer, Nuria Doménech Climent, Juan Antonio Virizuela Echaburu, Patricia Beorlegui Murillo, Maria Queralt Gorgas Torner
Ha sido reseñado en:
págs. 467-478
M. Mirrahimi, V. Hosseini, A. Shakeri Zadeh, Z. Alamzadeh, S.K. Kamrava, N. Attaran, Z. Abed, H. Ghaznavi, S.M.A. Hosseini Nami
págs. 479-488
A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study
N. Martínez Jáñez, M. Herrera, L. Frías, Mariano Provencio Pulla, R. Pérez Carrión, V. Díaz Díaz, Michael Morse, María del Carmen Crespo Lorenzo
págs. 489-498
O. Ercelep, O. Alan, D. Sahin, T.A. Telli, H. Salva, T.B. Tuylu, N.A. Babacan, S. Kaya, F. Dane, Tunç Öneş, H. Alkis, M. Adli, F. Yumuk
págs. 499-504
Víctor López López, P.B. Lynn, José Gil Martínez, Miguel García Salom, Elena Gil, A. Gonzalez, I.P. Muñoz, Pedro Antonio Cascales Campos
págs. 505-511
Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies
págs. 512-518
Quality indicators in radiation oncology: proposal of the Spanish Society of Radiation Oncology (SEOR) for a continuous improvement of the quality of care in oncology
José López Torrecilla, Susanna Marín i Borràs, Ana Ruiz Alonso, J. Jaén Olasolo, María Luisa Vázquez de la Torre, Elvira Boveda Carro, Aurora Rodríguez Pérez, Emilio Ignacio García, F. Caballero Martínez, F.J. Campos Lucas, Pedro Lara Jiménez, Jorge Contreras Martínez, Carlos Ferrer Albiach
págs. 519-533
Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)
Ana Santaballa Bertrán, Javier de Castro Carpeño, Joan Maurel Santasusana, Martin Lázaro Quintela, Ruth Vera García, Emilio Alba
págs. 534-538
© 2001-2024 Fundación Dialnet · Todos los derechos reservados